Company / Cash per Share
Anika Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.99
FY2025
5-year range
$3.79 / $6.59
FY2021-FY2025
Trend
+5.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2025 after 4 years of decline, reaching $3.99.
Based on SEC 10-K filings.
3.99 in FY2025 with a 5-year CAGR of -18.4%.
Declined from $4.70 to $3.99 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -12.6%
- 5-Year CAGR
- -18.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 5.1% year-over-year.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.99 | +5.1% |
| FY2024 | $3.79 | -19.3% |
| FY2023 | $4.70 | -21.4% |
| FY2022 | $5.98 | -9.2% |
| FY2021 | $6.59 | -40.1% |
| FY2020 | $11.01 | +75.6% |
| FY2019 | $6.27 | -11.7% |
| FY2018 | $7.10 | -6.2% |
| FY2017 | $7.57 | +13.6% |
| FY2016 | $6.66 | +56.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026